Abstract
This study was designed to evaluate the underlying protective mechanisms of oleuropein involved in alleviating brain damage in a rat model of ischemic stroke. Male Wistar rats were divided into four groups; Control, stroke (MCAO), MCAO + clopidogrel (Clop) and MCAO + oleuropein (Ole). Results showed that the MCAO group evidenced significant brain edema (+ 9%) as well as increases of plasma cardiac markers such as lactate deshydrogenase (LDH), creatine kinase (CK-MB), fibrinogen and Trop-T by 11 %, 43%, 168 and 590%, respectively, as compared to the control group. Moreover, infarcted rats exhibited remarkable elevated levels of angiotensin converting enzyme (ACE), both in plasma and brain tissue, with astrocyte swelling and necrotic neurons in the infarct zone, hyponatremia, and increased rate of thiobarbituric acid-reactive substances (TBARS) by 89% associated with decreases in the activity of superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (Cat) by 51%, 44 and 42%, respectively, compared to normal control rats. However, MCAO rats treated with oleuropein underwent mitigation of cerebral edema, correction of hyponatremia, remarkable decrease of plasma fibrinogen and cardiac dysfunctional enzymes, inhibition of ACE activity and improvement of oxidative stress status in brain tissue. Furthermore, in silico analysis showed considerable inhibitions of ACE, protein disulfide isomerase (PDI) and TGF-β1, an indicative of potent anti-embolic properties. Overall, oleuropein offers a neuroprotective effect against ischemic stroke through its antioxidative and antithrombotic activities.
Similar content being viewed by others
References
Donnan GA, Fisher M, Macleod M, Davis SM (2008) Stroke Lancet 371:1612–1623. https://doi.org/10.1016/S0140-6736(08)60694-7
Radu RA, Terecoasă EO, Băjenaru OA, Tiu C (2017) Etiologic classification of ischemic stroke: Where do we stand? Clin Neurol Neurosurg 159:93–106. https://doi.org/10.1016/j.clineuro.2017.05.019
Amarenco P, Bogousslavsky J, Caplan LR et al (2013) The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping). Cerebrovasc Dis 36:1–5. https://doi.org/10.1159/000352050
Benjamin EJ, Virani SS, Callaway CW et al (2018) Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 137:e67–e492. https://doi.org/10.1161/CIR.0000000000000558
Wajngarten M, Silva GS (2019) Hypertension and Stroke: Update on Treatment. Eur Cardiol 14:111–115. https://doi.org/10.15420/ecr.2019.11.1
Lorenzano S, Rost NS, Khan M et al (2018) Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke. Stroke 49:630–637. https://doi.org/10.1161/STROKEAHA.117.018440
Mnafgui K, Khdhiri E, Ghazouani L et al (2019) Anti-embolic and anti-oxidative effects of a novel (E)-4-amino-N’-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against isoproterenol and vitamin-K induced ischemic stroke. Arch Physiol Biochem. https://doi.org/10.1080/13813455.2019.1657900
Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron 67:181–198. https://doi.org/10.1016/j.neuron.2010.07.002
Broderick JP, Berkhemer OA, Palesch YY et al (2015) Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke: Pooled Analysis of IMS III and MR CLEAN Data. Stroke 46:3416–3422. https://doi.org/10.1161/STROKEAHA.115.011397
Bandla A, Liao L-D, Chan SJ et al (2018) Simultaneous functional photoacoustic microscopy and electrocorticography reveal the impact of rtPA on dynamic neurovascular functions after cerebral ischemia. J Cereb Blood Flow Metab 38:980–995. https://doi.org/10.1177/0271678.17712399
Dong M-X, Hu Q-C, Shen P et al (2016) Recombinant Tissue Plasminogen Activator Induces Neurological Side Effects Independent on Thrombolysis in Mechanical Animal Models of Focal Cerebral Infarction: A Systematic Review and Meta-Analysis. PLoS One 11:e0158848. https://doi.org/10.1371/journal.pone.0158848
Achour I, Arel-Dubeau A-M, Renaud J et al (2016) Oleuropein Prevents Neuronal Death, Mitigates Mitochondrial Superoxide Production and Modulates Autophagy in a Dopaminergic Cellular Model. Int J Mol Sci. https://doi.org/10.3390/ijms17081293
Casamenti F, Grossi C, Rigacci S et al (2015) Oleuropein Aglycone: A Possible Drug against Degenerative Conditions. In Vivo Evidence of its Effectiveness against Alzheimer’s Disease. JAD 45:679–688. https://doi.org/10.3233/JAD-142850
Mnafgui K, Hajji R, Derbali F et al (2015) Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat. Cardiovasc Toxicol 25:538–546. https://doi.org/10.1007/s12012-015-9323-1
Rigacci S, Stefani M (2016) Nutraceutical Properties of Olive Oil Polyphenols. Int J Mol Sci, An Itinerary from Cultured Cells through Animal Models to Humans. https://doi.org/10.3390/ijms17060843
Yu H, Liu P, Tang H et al (2016) Oleuropein, a natural extract from plants, offers neuroprotection in focal cerebral ischemia/reperfusion injury in mice. Eur J Pharmacol 775:113–119. https://doi.org/10.1016/j.ejphar.2016.02.027
Zhang W, Liu X, Li Q (2018) Protective Effects of Oleuropein Against Cerebral Ischemia/Reperfusion by Inhibiting Neuronal Apoptosis. Med Sci Monit 24:6587–6598. https://doi.org/10.12659/MSM.912336
Bank RPD RCSB PDB: Homepage. https://www.rcsb.org/. Accessed 3 Apr 2021
Pettersen EF, Goddard TD, Huang CC et al (2004) UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. https://doi.org/10.1002/jcc.20084
Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791. https://doi.org/10.1002/jcc.21256
Trott O, Olson AJ (2009) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem NA-NA. https://doi.org/10.1002/jcc.21334
Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778–2786. https://doi.org/10.1021/ci200227u
Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91. https://doi.org/10.1161/01.str.20.1.84
Fraga CG, Leibovitz BE, Tappel AL (1988) Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 4:155–161. https://doi.org/10.1016/0891-5849(88)90023-8
Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474. https://doi.org/10.1111/j.1432-1033.1974.tb03714.x
Flohé L, Günzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121. https://doi.org/10.1016/s0076-6879(84)05015-1
Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126. https://doi.org/10.1016/s0076-6879(84)05016-3
Benedek A, Móricz K, Jurányi Z et al (2006) Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res 1116:159–165. https://doi.org/10.1016/j.brainres.2006.07.123
Daopin S, Piez KA, Ogawa Y, Davies DR (1992) Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science 257:369–373. https://doi.org/10.1126/science.1631557
Feigin VL, Norrving B, Mensah GA (2017) Global Burden of Stroke. Circ Res 120:439–448. https://doi.org/10.1161/CIRCRESAHA.116.308413
Kaiser EE, Waters ES, Fagan MM et al (2020) Characterization of tissue and functional deficits in a clinically translational pig model of acute ischemic stroke. Brain Res 1736:146778. https://doi.org/10.1016/j.brainres.2020.146778
Zhang Y, Yan Y, Cao Y et al (2017) Potential therapeutic and protective effect of curcumin against stroke in the male albino stroke-induced model rats. Life Sci 183:45–49. https://doi.org/10.1016/j.lfs.2017.06.023
Hjort N, Butcher K, Davis SM et al (2005) Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 36:388–397. https://doi.org/10.1161/01.STR.0000152268.47919.be
Fofi L, Dall’armi V, Durastanti L et al (2012) An observational study on electrolyte disorders in the acute phase of ischemic stroke and their prognostic value. J Clin Neurosci 19:513–516. https://doi.org/10.1016/j.jocn.2011.07.041
Liamis G, Barkas F, Megapanou E et al (2019) Hyponatremia in Acute Stroke Patients: Pathophysiology, Clinical Significance, and Management Options. Eur Neurol 82:32–40. https://doi.org/10.1159/000504475
Mohagheghi F, Bigdeli MR, Rasoulian B et al (2011) The neuroprotective effect of olive leaf extract is related to improved blood-brain barrier permeability and brain edema in rat with experimental focal cerebral ischemia. Phytomedicine 18:170–175. https://doi.org/10.1016/j.phymed.2010.06.007
Faiz KW, Thommessen B, Einvik G et al (2014) Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:241–248. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.005
Jensen JK, Atar D, Mickley H (2007) Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol 99:867–870. https://doi.org/10.1016/j.amjcard.2006.10.052
Janahmadi Z, Nekooeian AA, Moaref AR, Emamghoreishi M (2015) Oleuropein offers cardioprotection in rats with acute myocardial infarction. Cardiovasc Toxicol 15:61–68. https://doi.org/10.1007/s12012-014-9271-1
Danesh J, Lewington S, Thompson SG et al (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 294:1799–1809. https://doi.org/10.1001/jama.294.14.1799
Machlus KR, Cardenas JC, Church FC, Wolberg AS (2011) Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood 117:4953–4963. https://doi.org/10.1182/blood-2010-11-316885
Jastrzebska M, Torbus-Lisiecka B, Honczarenko K et al (2002) Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children. Nutr Metab Cardiovasc Dis 12:132–140
van Hylckama Vlieg A, Rosendaal FR (2003) High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J Thromb Haemost 1:2677–2678. https://doi.org/10.1111/j.1538-7836.2003.0543b.x
Radaev S, Zou Z, Huang T et al (2010) Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily. J Biol Chem 285:14806–14814. https://doi.org/10.1074/jbc.M109.079921
Wang X, Xue G, Song M et al (2018) Molecular basis of rutin inhibition of protein disulfide isomerase (PDI) by combined in silico and experimental methods. RSC Adv 8:18480–18491. https://doi.org/10.1039/C8RA02683A
Elmazoglu Z, Ergin V, Sahin E et al (2017) Oleuropein and rutin protect against 6-OHDA-induced neurotoxicity in PC12 cells through modulation of mitochondrial function and unfolded protein response. Interdisciplinary Toxicology 10:129–141. https://doi.org/10.1515/intox-2017-0019
Mnafgui K, Khdhiri E, Hajji R et al (2020) Potential effect of new (E)-4-hydroxy -N’-(1-(7-hydroxy-2-oxo-2H-chromen-3-yl) ethylidene) benzohydrazide against acute myocardial infarction: Haemodynamic, biochemical and histological studies. Clin Exp Pharmacol Physiol 48:107–120. https://doi.org/10.1111/1440-1681.13397
Wang W, Ma X, Han J et al (2016) Neuroprotective Effect of Scutellarin on Ischemic Cerebral Injury by Down-Regulating the Expression of Angiotensin-Converting Enzyme and AT1 Receptor. PLoS One. https://doi.org/10.1371/journal.pone.0146197
Ongali B, Nicolakakis N, Tong X-K, Lecrux C (2018) Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways. Can J Physiol Pharmacol 96(5):527–534. https://doi.org/10.1139/cjpp-2017-0640
Sun W, Wang X, Hou C et al (2017) Oleuropein improves mitochondrial function to attenuate oxidative stress by activating the Nrf2 pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats. Neuropharmacology 113:556–566. https://doi.org/10.1016/j.neuropharm.2016.11.010
Acknowledgements
This research was supported by the Tunisian Ministry of Higher Education and Scientific Research and the Tunisian Ministry of Public Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no competing interests associated with the manuscript.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mnafgui, K., Ghazouani, L., Hajji, R. et al. Oleuropein Protects Against Cerebral Ischemia Injury in Rats: Molecular Docking, Biochemical and Histological Findings. Neurochem Res 46, 2131–2142 (2021). https://doi.org/10.1007/s11064-021-03351-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-021-03351-9